GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Sunflower Great Health Co Ltd (SZSE:300111) » Definitions » YoY EBITDA Growth

Zhejiang Sunflower Great Health Co (SZSE:300111) YoY EBITDA Growth : -93.75% (As of Sep. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Zhejiang Sunflower Great Health Co YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Zhejiang Sunflower Great Health Co's YoY EBITDA Growth for the quarter that ended in Sep. 2024 was -93.75%.

Zhejiang Sunflower Great Health Co's EBITDA per Share for the three months ended in Sep. 2024 was ¥0.00.


Zhejiang Sunflower Great Health Co YoY EBITDA Growth Historical Data

The historical data trend for Zhejiang Sunflower Great Health Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Sunflower Great Health Co YoY EBITDA Growth Chart

Zhejiang Sunflower Great Health Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 100.25 4,000.00 -2.44 -76.25 94.74

Zhejiang Sunflower Great Health Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,166.67 -76.19 106.25 -50.00 -93.75

Zhejiang Sunflower Great Health Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Zhejiang Sunflower Great Health Co's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(0.037-0.019)/ | 0.019 |
=94.74 %

Zhejiang Sunflower Great Health Co's YoY EBITDA Growth for the quarter that ended in Sep. 2024 is calculated as:

YoY EBITDA Growth (Q: Sep. 2024 )
=(EBITDA per Share (Q: Sep. 2024 )-EBITDA per Share (Q: Sep. 2023 )) / | EBITDA per Share (Q: Sep. 2023 )) |
=(0.002-0.032)/ | 0.032 |
=-93.75 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhejiang Sunflower Great Health Co YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Zhejiang Sunflower Great Health Co's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Sunflower Great Health Co Business Description

Traded in Other Exchanges
N/A
Address
Sanjiang Road, Paojiang Industrial Zone, Zhejiang, Shaoxing, CHN, 312071
Zhejiang Sunflower Great Health Co Ltd operates in pharmaceutical manufacturing industry.
Executives
Yu Xiang Ming Director
Lin Dan Ping Director
Zheng Zhi Dong Executives
Li Lan Securities Affairs Representative
Yang Wang Xiang Directors, Directors, and Executives
Ding Guo Jun Directors, executives
Pan Wei Biao Directors, executives
Chen Hai Tao Executives
Wu Cai Miao Supervisors
Zhou Xiao Bing Executives

Zhejiang Sunflower Great Health Co Headlines

No Headlines